Clinical Trial Update: To Evaluate Long- Term Safety and Efficacy of Luspatercept

View source ↗

Summary

An update on a long-term safety and efficacy study of luspatercept in thalassemia major; the trial is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Major

Drugs mentioned

• REBLOZYL (LUSPATERCEPT)

Snippet

Sponsor: Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia | Conditions: Thalassemia Major | Status: ACTIVE_NOT_RECRUITING